Literature DB >> 29709682

Low subcutaneous adiposity associates with higher mortality in female patients with cirrhosis.

Maryam Ebadi1, Puneeta Tandon1, Carlos Moctezuma-Velazquez1, Sunita Ghosh2, Vickie E Baracos2, Vera C Mazurak3, Aldo J Montano-Loza4.   

Abstract

BACKGROUND & AIMS: Two major body compartments, skeletal muscle and adipose tissue, exhibit independent functions. We aimed to explore the prognostic significance of skeletal muscle, visceral and subcutaneous adipose tissue, according to sex, in patients with cirrhosis assessed for liver transplantation (LT).
METHODS: CT images taken at the 3rd lumbar vertebra from 677 patients were quantified for three body composition indexes (cm2/m2), visceral adipose tissue index, subcutaneous adipose tissue index (SATI), and skeletal muscle index (SMI). Cox proportional and competing-risk analysis hazard models were conducted to assess associations between mortality and body composition.
RESULTS: The majority of patients were male (67%) with a mean age of 57 ± 7 years, model for end-stage liver disease (MELD) score of 14 ± 8 and mean body mass index of 27 ± 6 kg/m2. Despite similar body mass index between the sexes, male patients had greater SMI (53 ± 12 vs. 45 ± 9 cm2/m2), whereas SATI (67 ± 52 vs. 48 ± 37 cm2/m2) was higher in females (p <0.001 for each). In sex stratified multivariate analyses after adjustment for MELD score and other confounding variables, SATI in females (hazard ratio [HR] 0.99; 95% CI 0.98-1.00; p = 0.01) and SMI in males (HR 0.98; 95% CI 0.96-1.00; p = 0.02) were significant predictors of mortality. Female patients with low SATI (<60 cm2/m2) had a higher risk of mortality (HR 2.06; 95% CI 1.08-3.91; p = 0.03). Using competitive risk analysis in female patients listed for LT, low SATI was also an independent predictor of mortality (subdistribution HR 2.80; 95% CI 1.28-6.12; p = 0.01) after adjusting for MELD, and other confounding factors.
CONCLUSIONS: A lower SATI is associated with higher mortality in female patients with cirrhosis. Subcutaneous adipose tissue has a favorable metabolic profile - low SATI may reflect depletion of this major energy reservoir, leading to poor clinical outcomes. LAY
SUMMARY: We looked at the importance of two of the main body compartments, skeletal muscle and adipose tissue (fat) on the prognosis of males and females with end-stage liver disease. Lower amounts of subcutaneous fat but not visceral fat (around internal organs), are associated with higher mortality in female patients with end-stage liver disease. However, low skeletal muscle predicts mortality in male patients with end-stage liver disease.
Copyright © 2018. Published by Elsevier B.V.

Entities:  

Keywords:  Adipose tissue; Body composition; Computed tomography; End-stage liver disease; Survival

Mesh:

Year:  2018        PMID: 29709682     DOI: 10.1016/j.jhep.2018.04.015

Source DB:  PubMed          Journal:  J Hepatol        ISSN: 0168-8278            Impact factor:   25.083


  28 in total

1.  A North American Expert Opinion Statement on Sarcopenia in Liver Transplantation.

Authors:  Elizabeth J Carey; Jennifer C Lai; Christopher Sonnenday; Elliot B Tapper; Puneeta Tandon; Andres Duarte-Rojo; Michael A Dunn; Cynthia Tsien; Eric R Kallwitz; Vicky Ng; Srinivasan Dasarathy; Matthew Kappus; Mustafa R Bashir; Aldo J Montano-Loza
Journal:  Hepatology       Date:  2019-08-19       Impact factor: 17.425

2.  Hepatitis C Virus Cure and Obesity: Watch the Weight.

Authors:  Nizar A Mukhtar; Rena K Fox
Journal:  J Gen Intern Med       Date:  2020-10       Impact factor: 5.128

3.  The improvement in body composition including subcutaneous and visceral fat reduces ammonia and hepatic encephalopathy after transjugular intrahepatic portosystemic shunt.

Authors:  Stefania Gioia; Lorenzo Ridola; Ludovica Cristofaro; Manuela Merli; Jessica Faccioli; Oliviero Riggio; Silvia Nardelli
Journal:  Liver Int       Date:  2021-09-28       Impact factor: 8.754

4.  Sarcopenic visceral obesity is associated with increased post-liver transplant mortality in acutely ill patients with cirrhosis.

Authors:  Nghiem B Ha; Aldo J Montano-Loza; Elizabeth J Carey; Shezhang Lin; Amy M Shui; Chiung-Yu Huang; Michael A Dunn; Jennifer C Lai
Journal:  Am J Transplant       Date:  2022-05-13       Impact factor: 9.369

Review 5.  Nutrition in Chronic Liver Disease.

Authors:  Yala Kirthi Reddy; Benedict Maliakkal; Uchenna Agbim
Journal:  Curr Treat Options Gastroenterol       Date:  2019-12

6.  Sarcopenia HIBA score predicts sarcopenia and mortality in patients on the liver transplant waiting list.

Authors:  Ezequiel Mauro; Juan Manuel Diaz; Lucrecia Garcia-Olveira; Juan Carlos Spina; Lorena Savluk; Fernanda Zalazar; Julia Saidman; Martin De Santibañes; Juan Pekolj; Eduardo De Santibañes; Gonzalo Crespo; Juan G Abraldes; Adrían Gadano
Journal:  Hepatol Commun       Date:  2022-03-03

Review 7.  Nutrition in Chronic Liver Disease: Consensus Statement of the Indian National Association for Study of the Liver.

Authors:  Pankaj Puri; Radha K Dhiman; Sunil Taneja; Puneeta Tandon; Manuela Merli; Anil C Anand; Anil Arora; Subrat K Acharya; Jaya Benjamin; Yogesh K Chawla; Sunil Dadhich; Ajay Duseja; C E Eapan; Amit Goel; Naveen Kalra; Dharmesh Kapoor; Ashish Kumar; Kaushal Madan; Aabha Nagral; Gaurav Pandey; Padaki N Rao; Sanjiv Saigal; Neeraj Saraf; Vivek A Saraswat; Anoop Saraya; Shiv K Sarin; Praveen Sharma; Akash Shukla; Sandeep S Sidhu; Namrata Singh; Shivaram P Singh; Anshu Srivastava; Manav Wadhawan
Journal:  J Clin Exp Hepatol       Date:  2020-10-01

Review 8.  Assessment of the Frail Patient With End-Stage Liver Disease: A Practical Overview of Sarcopenia, Physical Function, and Disability.

Authors:  Felicity R Williams; Don Milliken; Jennifer C Lai; Matthew J Armstrong
Journal:  Hepatol Commun       Date:  2021-02-26

Review 9.  Pathophysiology of decompensated cirrhosis: Portal hypertension, circulatory dysfunction, inflammation, metabolism and mitochondrial dysfunction.

Authors:  Cornelius Engelmann; Joan Clària; Gyongyi Szabo; Jaume Bosch; Mauro Bernardi
Journal:  J Hepatol       Date:  2021-07       Impact factor: 30.083

10.  Visceral Adipose Tissue Inflammation and Radiographic Visceral-to-Subcutaneous Adipose Tissue Ratio in Patients with Cirrhosis.

Authors:  Nghiem B Ha; Soo-Jin Cho; Yara Mohamad; Dorothea Kent; Grace Jun; Randi Wong; Vivek Swarnakar; Shezhang Lin; Jacquelyn J Maher; Jennifer C Lai
Journal:  Dig Dis Sci       Date:  2021-06-16       Impact factor: 3.487

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.